Search ECOC
ABVC BIOPHARMA, INC.
Nasdaq, OTC · CIK 1173313
Last close0.05
Daily change+0.00 (0.00%)
10 Years gain+1900.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ECOC · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
58.9Momentum
100.0Acceleration
100.0Confidence
83.0Annual Revenue13
Quarterly Revenue44
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.7 / 25
Quality19.7 / 25
Capital Efficiency11.1 / 20
Balance Sheet2.4 / 15
Shareholder Economics5.7 / 10
Forward Indicators2.3 / 5
Signals
Gross margin expansionGross margin improved by 954.4161 percentage points.
Operating leverageOperating margin improved by 30060.7333 percentage points.
ROIC expansionROIC improved by 278.8022 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Heavy share dilution · HIGHDiluted share count increased 138.8684%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM5,042.66%OK
Revenue CAGR 3Y12.72%OK
Gross Margin99.96%OK
Operating Margin-293.74%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-40.18%OK
Incremental Operating Margin 3Y1,082.66%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y138.87%OK
SBC / Revenue143.99%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $0.00 | -$7.15M | -$2.99M | n/a | n/a | n/a | n/a | -87.76% | 20.11M |
| 2025 FY Dec 31, 2024 | $509,589.00 | $508,826.00 | -$4.71M | -$1.81M | n/a | 99.85% | -923.34% | n/a | -182.79% | 11.67M |
| 2024 FY Dec 31, 2023 | $152,430.00 | -$149,607.00 | -$6.77M | -$4.19M | -$4.21M | -98.15% | -4,439.24% | -2,760.64% | -149.63% | 4.34M |
| 2023 FY Dec 31, 2022 | $969,783.00 | $683,368.00 | -$15.11M | -$7.40M | -$7.52M | 70.47% | -1,558.54% | -775.23% | -254.64% | 3.17M |
| 2022 FY Dec 31, 2021 | $355,797.00 | $350,711.00 | -$11.71M | -$7.60M | -$7.62M | 98.57% | -3,290.07% | -2,140.33% | -346.29% | 25.05M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.30M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-25-075644, 0001213900-26-023062 |
| Revenue Growth TTM | 5,042.66% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-25-075644, 0001213900-26-023062 |
| Revenue CAGR 3Y | 12.72% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-023063 |
| Revenue CAGR 5Y | -6.2% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-023063 |
| Gross Profit CAGR 3Y | 13.21% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-023063 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-25-075644, 0001213900-26-023062 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 99.96% | Gross Profit / Revenue | OK | 0001213900-25-075644, 0001213900-26-023062 |
| Operating Margin | -293.74% | Operating Income / Revenue | OK | 0001213900-25-075644, 0001213900-26-023062 |
| ROIC | -40.18% | NOPAT / Average Invested Capital | OK | 0001213900-25-075644, 0001213900-26-023062 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001213900-26-023062 |
| Current Ratio | 0.51x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.32x | (Cash + Short-term Investments) / Total Debt | OK | 0001213900-26-023062 |
| SBC / Revenue | 143.99% | SBC / Revenue | OK | 0001213900-25-075644, 0001213900-26-023062 |